Skip to content

Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study

Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02528331
Acronym
CBT-TMS
Enrollment
2
Registered
2015-08-19
Start date
2016-03-31
Completion date
2016-08-31
Last updated
2017-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive Disorder (OCD)

Keywords

Transcranial magnetic stimulation (TMS), Cognitive behavioral therapy (CBT)

Brief summary

The purpose of this study is to evaluate the effectiveness of repetitive TMS (rTMS) delivered simultaneously with elements of cognitive behavioral therapy/exposure-response prevention (CBT/ERP) in adult subjects (greater or equal to 18 years old) with obsessive-compulsive disorder (OCD). This is an open label study that involves standard of care for OCD (CBT) and an investigational treatment modality (TMS). The investigators will compare the Yale-Brown Obsessive Compulsive Scale (YBOCS) scores before and after treatment to quantify clinical improvement. The side effects from TMS include, but are not limited to, headache, seizure, and general pain. CBT has minimal side effects other than mental discomfort during the exposure sessions. For safety concerns, pregnant women and subjects with seizure-related history will be excluded as well as other indicated conditions in the details protocol.

Interventions

DEVICETranscranial magnetic stimulation
BEHAVIORALCognitive behavioral therapy

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects must meet all of the following inclusion criteria to qualify for enrollment into the study: 1. All subjects will be 18 - 65 years of age. 2. Obsessive-compulsive disorder: * Subjects will meet the DSM-IV primary diagnosis of obsessive-compulsive * Y-BOCS total score \> 16 3. Subjects are willing and able to adhere to the intensive treatment schedule and all required study visits.

Exclusion criteria

Subjects will be excluded from study participation if one of the following

Design outcomes

Primary

MeasureTime frameDescription
Remission Rate, as Measured by Y-BOCS6 weeksRemission is defined as end-point Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score less than the value of 16.

Secondary

MeasureTime frameDescription
Complete Response, as Measured by Y-BOCS6 weeksComplete response is defined as a reduction of Y-BOCS score greater than 35%.
Partial Response Rate, as Measured by Y-BOCS6 weeksPartial response is defined as a reduction of greater than 25%.
Percentage of Adverse Events6 weeks

Countries

United States

Participant flow

Participants by arm

ArmCount
rTMS and Cognitive Behavior Therapy
Transcranial magnetic stimulation Cognitive behavioral therapy
2
Total2

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicrTMS and Cognitive Behavior Therapy
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
Age, Continuous51.5 years
Gender
Female
1 Participants
Gender
Male
1 Participants
Region of Enrollment
United States
2 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 2
serious
Total, serious adverse events
0 / 2

Outcome results

Primary

Remission Rate, as Measured by Y-BOCS

Remission is defined as end-point Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score less than the value of 16.

Time frame: 6 weeks

ArmMeasureValue (NUMBER)
rTMS and Cognitive Behavior TherapyRemission Rate, as Measured by Y-BOCS50 percentage of participants
Secondary

Complete Response, as Measured by Y-BOCS

Complete response is defined as a reduction of Y-BOCS score greater than 35%.

Time frame: 6 weeks

ArmMeasureValue (NUMBER)
rTMS and Cognitive Behavior TherapyComplete Response, as Measured by Y-BOCS50 percentage of participants
Secondary

Partial Response Rate, as Measured by Y-BOCS

Partial response is defined as a reduction of greater than 25%.

Time frame: 6 weeks

ArmMeasureValue (NUMBER)
rTMS and Cognitive Behavior TherapyPartial Response Rate, as Measured by Y-BOCS50 percentage of participants
Secondary

Percentage of Adverse Events

Time frame: 6 weeks

ArmMeasureValue (NUMBER)
rTMS and Cognitive Behavior TherapyPercentage of Adverse Events0 percentage of adverse events

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026